Me10 Where does it hurt - lisa sullivan
Upcoming SlideShare
Loading in...5
×
 

Me10 Where does it hurt - lisa sullivan

on

  • 340 views

 

Statistics

Views

Total Views
340
Views on SlideShare
340
Embed Views
0

Actions

Likes
0
Downloads
6
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Me10 Where does it hurt - lisa sullivan Me10 Where does it hurt - lisa sullivan Presentation Transcript

    • 52nd ICCA Congress ME10: “Where does it hurt?” Can international healthcare meetings evolve swiftly enough to meet the pressures to become more transparent, more educationally effective, and still remain financially viable? Lisa Sullivan: Principle at In Vivo Communications Associate at WentzMiller Global Services International Congress and Convention Association . Twitter: #ICCA13
    • My affiliations • Principle at In Vivo Communications – a medical communications agency covering medical meetings, medical education (CME/CPD) and medical communications (all HCPs) - Offices in Singapore and Sydney • Associate at WentzMiller Global Services: a global consulting company specialising in CME/CPD strategy, development and delivery - Responsible for Asia and Australia • Board member Global Alliance for Medical Education (GAME) International Congress and Convention Association . Twitter: #ICCA13
    • Disclosures I have an interest in selling medical meetings and CEPD programs to professionals across Australasia including eLearning, distance learning and face-to-face programmes International Congress and Convention Association . Twitter: #ICCA13
    • My coverage International Congress and Convention Association . Twitter: #ICCA13
    • APAC Meeting Environment -Traditionally ▪ Meetings are more face to face than in other regions ▪ Events range from small advisory board meetings (both regionally and locally) to large stand alone symposia ▪ Advisory Board meetings popular, are usually regional with 15-25 KOLs ▪ Regularly sponsor satellite meetings at large international congresses ▪ Technology at these meeting is standard with presentations all done via PPT slides sometimes with the use of keypads for voting ▪ 5 star hotels and resorts used to be the standard venue International Congress and Convention Association . Twitter: #ICCA13
    • APAC Meeting Environment - Currently ▪ Event formats have not changed much except there is greater importance on the science rather than the ‘sell’ ▪ Korea’s strict pharma code restricts Korean KOL involvement in regional meetings unless the Korean is a speaker or chair ▪ Technology is growing in importance as clients request virtual meetings (especially Advisory Boards) ▪ Acceptable venues have moved from 5 star to 4 star almost overnight ▪ Convention Centres used for large congresses or “stand alone” meetings ▪ CME/CPD is very different in Asia than the US and even Australia – less rules and less accreditation International Congress and Convention Association . Twitter: #ICCA13
    • APAC Meeting Environment - Future ▪ Technology will take a much greater role due to cost and convenience ▪ Technology critical for Korean’s to participate in regional discussions especially when Korea is a key Asian market ▪ Funding management moving from Marketing to Procurement thus margins are squeezed - affordability is the key...technology must play a role here ▪ Pharma code compliance will continue to strengthen especially on the back of the GSK China issues ▪ Congress spend from Pharma will continue to diminish ▪ CME/CPD will take on a greater role, will be accredited and will require much more science AND will move towards the grant process which exists in the US International Congress and Convention Association . Twitter: #ICCA13
    • Sunshine Act ▪ ▪ ▪ ▪ ▪ ▪ To date there appears to be little knowledge in Asia or Australia of how Sunshine will affect international meetings in our region Pfizer US has already confirmed a requirement to record all “value” provided to US Drs who attend Asian meetings The major impact will be for US speakers who come to Asia/Australia and for satellite symposia where US Drs are in attendance Now that Europe is also introducing their own version of Sunshine how long will it be before ROW is also talking and implementing this? Who will pay the extra costs - organisational and reporting? Will it impact registration fees and are non US Pharma ready for the cost burden of compliance and reporting? Asian and Australian Pharma affiliates are completely unaware and unprepared International Congress and Convention Association . Twitter: #ICCA13
    • Thank you Questions?? International Congress and Convention Association . Twitter: #ICCA13